Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 2
2012 1
2015 1
2018 1
2019 2
2020 1
2021 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
[Work sampling in ophthalmological clinical studies. A multicenter field study].
Böhringer D, Goos D, Ach T, Feltgen N, Fleckenstein M, Kohnen T, Lorenz K, Pielen A, Spital G, Wilhelm B, Böhringer S, Reinhard T; Arbeitsgemeinschaft DOG – Klinische Studienzentren. Böhringer D, et al. Among authors: goos d. Ophthalmologe. 2019 Sep;116(9):872-878. doi: 10.1007/s00347-019-0851-0. Ophthalmologe. 2019. PMID: 30684005 German.
FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States.
Hantash FM, Goos DM, Crossley B, Anderson B, Zhang K, Sun W, Strom CM. Hantash FM, et al. Among authors: goos dm. Genet Med. 2011 Jan;13(1):39-45. doi: 10.1097/GIM.0b013e3181fa9fad. Genet Med. 2011. PMID: 21116185 Free article.
Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening.
Hantash FM, Goos DG, Tsao D, Quan F, Buller-Burckle A, Peng M, Jarvis M, Sun W, Strom CM. Hantash FM, et al. Among authors: goos dg. Genet Med. 2010 Mar;12(3):162-73. doi: 10.1097/GIM.0b013e3181d0d40e. Genet Med. 2010. PMID: 20168238 Free article.